| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Feb 01, 2024 | Sale | $15.78 | 4,993 | 78,790 | 23,414 | Feb 05, 2024, 09:16 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Jan 31, 2024 | Sale | $15.74 | 4,993 | 78,590 | 23,414 | Feb 02, 2024, 07:12 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Aug 31, 2023 | Sale | $18.01 | 3,800 | 68,438 | 18,407 | Sep 05, 2023, 04:28 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Jan 31, 2023 | Sale | $10.12 | 1,636 | 16,556 | 13,873 | Feb 02, 2023, 01:04 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Aug 31, 2022 | Sale | $7.21 | 3,606 | 25,999 | 12,176 | Sep 02, 2022, 11:40 AM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Jan 31, 2022 | Sale | $7.58 | 414 | 3,138 | 7,449 | Feb 02, 2022, 04:35 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | Nov 30, 2021 | Sale | $12.03 | 3,803 | 45,750 | 7,030 | Dec 02, 2021, 01:16 PM | |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | May 17, 2021 | Buy | $15.71 | 2,500 | 39,275 | 2,500 | May 18, 2021, 11:35 AM |
Menu